Article

Obesity, depression, anxiety, and illness beliefs influence remission, pain, and fatigue in RA


 

Key clinical point: Obesity, anxiety, depression, and illness perception at baseline were associated with treatment outcomes, pain, and fatigue in patients with rheumatoid arthritis (RA).

Major finding: At 12 months , obesity vs. normal weight was associated with a lower likelihood of remission (adjusted odds ratio [aOR], 0.33; P=.005). Obesity and illness perception were significantly associated with pain (aOR, 8.16; P = .002 and aOR, 0.62; P < .001, respectively) and fatigue (aOR, 5.66; P = .049 and aOR, 0.51; P = .001, respectively) with patients with severe vs. no a nxiety having higher pain (aOR, 9.60; P = .010) and those with severe (aOR, 17.07; P < .001) and moderate (aOR, 10.13; P = .001) depression having higher fatigue .

Study details: This secondary analysis of the TITRATE trial included 335 patients with RA treated with intensive management (n=168) or standard care (n=167).

Disclosures: This study was funded by the National Institute for Health Research. E Nikiphorou received speaker fees and served on advisory boards for various sources. Other authors declared no competing interest.

Source: Lee SY et al. Arthritis Res Ther. 2021 Nov 4. doi: 10.1186/s13075-021-02653-1 .

Recommended Reading

When a JAK inhibitor fails for a patient with RA, what’s next?
MDedge Rheumatology
mRNA COVID vaccine response found mostly robust in RA, SLE patients
MDedge Rheumatology
Tofacitinib postmarketing trial data shed light on JAK inhibitor risks
MDedge Rheumatology
Long-term glucocorticoids in RA linked to increased cardiovascular risk
MDedge Rheumatology
Low-dose rituximab may keep RA disease activity low in responders
MDedge Rheumatology
No risk of increased flare after 2 doses of COVID-19 vaccination in RA
MDedge Rheumatology
RA: bDMARD monotherapy may accelerate radiographic progression of preexisting distal hand osteoarthritis
MDedge Rheumatology
Baricitinib demonstrates consistent long-term safety profile in RA
MDedge Rheumatology
T-helper cell derangements tied to atrial fibrillation in RA
MDedge Rheumatology
Certolizumab seems effective as monotherapy in RA patients with failure to csDMARDs
MDedge Rheumatology